Plant Foods for Human Nutrition

, Volume 63, Issue 3, pp 141–145 | Cite as

Hepatic Protection by Noni Fruit Juice Against CCl4-Induced Chronic Liver Damage in Female SD Rats

  • Mian-Ying Wang
  • Gary Anderson
  • Diane Nowicki
  • Jarakae Jensen
Original Paper

Abstract

Morinda citrifolia L. (noni) has been used throughout the Pacific, Southeast Asia, Central America, and the Caribbean for a variety of health conditions, including heart and liver ailments. In this study, we examined the hepatoprotective effects of TAHITIAN NONI® Juice (TNJ) against CCl4-induced chronic liver damage in female Sprague Dawley (SD) rats. Twelve female SD rats were divided into control, placebo and TNJ (6 mL/rat/day) groups. On day 15, animals in the placebo and TNJ groups received 0.25 mL/kg CCl4 in corn oil once a week for 12 successive weeks. All animals were sacrificed at week 16. Blood and liver were collected for liver function, lipid panel tests, and histological observation. Histopathological examination revealed that liver sections from the TNJ + CCl4 appeared similar to controls, whereas typical hepatic steatosis was observed in the placebo + CCl4 group. Serum alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine transaminase (ALT), total cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL), and very low-density lipoprotein (VLDL) levels were increased in the placebo group compared with the TNJ group. In contrast, high-density lipoprotein (HDL) was increased in the TNJ group and decreased in the placebo group. Thus, TNJ juice appears to protect the liver from chronic exogenous CCl4 exposures. Such protective mechanisms are supportive evidence for the utility of noni in traditional medicine for liver ailments.

Keywords

Morinda citrifolia L. (Rubiaceae) (noni) Carbon tetrachloride Hepatic protection 

Notes

Acknowledgements

This study was financially supported by Research grant of Morinda Holdings Inc. We thank Dr. Richard Novak and Dr. Leland White for editing the article and manuscript preparation. We thank Brett J. West for formulation and production of the placebo. We thank the clinical technicians of the laboratory of Family Health Center of UIC College of Medicine for their technical help in the liver function and lipid panel tests. A special thanks is extended to Mr. John Javaherian for his efforts on animal care.

References

  1. 1.
    Wang MY, West BJ, Jensen CJ, Nowicki D, Chen S, Palu A, Anderson G (2002) Morinda citrifolia (Noni) a literature review and recent advances in noni research. Acta Pharmacol Sin 23(12):1127–1141Google Scholar
  2. 2.
    Glassman SF (1952) The flora of Ponape. Honolulu (Hi): B.P. Bishop Museum, Bulletin 209; 152 ppGoogle Scholar
  3. 3.
    Burkill IH (1966) A dictionary of the economic products of the Malay Peninsula. vol II. Kuala Lumpur (Malaysia): Ministry of Agriculture and Co-operatives; p 1515–1519Google Scholar
  4. 4.
    Morton JF (1981) Atlas of medicinal plants of Middle America: Bahamas to Yucatan. Springfield (Ill): C.C. Thomas. Figure 463, Morinda citrifolia; p 868Google Scholar
  5. 5.
    Kamiya K, Tanaka Y, Endang H, Umar M, Satake T (2004) Chemical constituents of Morinda citrifolia fruits inhibit copper-induced low-density lipoprotein oxidation. J Agric Food Chem 52:5843–5848CrossRefGoogle Scholar
  6. 6.
    Su B-N, Pawlus AD, Jung H-A, Keller WJ, McLaughlin JL, Kinghorn DA (2005) Chemical constituents of the fruits of Morinda citrifolia (Noni) and their antioxidant activity. J Nat Products 68:592–595CrossRefGoogle Scholar
  7. 7.
    Deng S, Palu K, West BJ, Su CX, Zhou BN, Jensen JC (2007) Lipoxygenase inhibitory constituents of the fruits of noni (Morinda citrifolia) collected in Tahiti. J Nat Products 70:859–862CrossRefGoogle Scholar
  8. 8.
    Zin ZM, Hamid AA, Osman A, Saari N, Misran A (2007) Isolation and identification of antioxidative compound from fruit of Mengkudu (Morinda citrifolia L.). Int J Food Prop 10:363–373CrossRefGoogle Scholar
  9. 9.
    Czaja MJ, Xu J, Alt E (1995) Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology 108:1849–1854CrossRefGoogle Scholar
  10. 10.
    Naziroglu M, Cay M, Ustundag B, Aksakal M, Yekeler H (1999) Protective effects of vitamin E on carbon tetrachloride-induced liver damage in rats. Cell Biochem Funct 17:253–259CrossRefGoogle Scholar
  11. 11.
    Williams AT, Burk RF (1990) Carbon tetrachloride hepatotoxicity: an example of free radical-mediated injury. Semin Liver Dis 10:279–284CrossRefGoogle Scholar
  12. 12.
    Parola M, Leonarduzzi G, Biasi F, Albano E, Biocca ME, Poli G, Dianzani MU (1992) Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis. Hepatology 16:1014–1021CrossRefGoogle Scholar
  13. 13.
    Biggerstaff KD, Wooten JS (2004) Understanding lipoproteins as transporters of cholesterol and other lipids. Adv Physiol Educ 28:105–106CrossRefGoogle Scholar
  14. 14.
    Vienken J, Christmann H (2006) How can liver toxins be removed? Filtration and adsorption with the Prometheus system. Ther Apher Dial 10:125–131CrossRefGoogle Scholar
  15. 15.
    Klimov AN, Popov AV, Nagornev VA, Pleskov VM (1985) Effect of high density lipoproteins on permeability of rabbit aorta to low density lipoproteins. Atherosclerosis 55:217–223CrossRefGoogle Scholar
  16. 16.
    Habib SS (2004) Lipoprotein(a): the bad cholesterol. Saudi Med J 25:429–433Google Scholar
  17. 17.
    Hodoglugil U, Mahley RW (2006) Smoking and obesity make a bad problem worse: genetics and lifestyle affect high density lipoprotein levels in Turks. Anadolu Kardiyol Dergisi 6:60–67Google Scholar
  18. 18.
    Baratta PF, Angeli G, Lusiani GB, Cavazzuti F (1954) Effect of heparin on hepatic steatosis due to hypercholesterol diet. Bollettino-Societa Italiana Biologia Sperimentale (Napoli) 30:164–166Google Scholar
  19. 19.
    Adiels M, Westerbacka J, Soro-Paavonen A, Häkkinen AM, Vehkavaara S, Caslake MJ, Packard C, Olofsson SO, Yki-Järvinen H, Taskinen MR, Borén J (2006) Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49:755–765CrossRefGoogle Scholar
  20. 20.
    Williams R (2006) Global challenges in liver disease. Hepatology 44:521–526CrossRefGoogle Scholar
  21. 21.
    Huxley R, Lewington S, Clarke R (2002) Cholesterol, coronary heart disease and stroke: a review of published evidence from observational studies and randomized controlled trials. Semin Vasc Med 2:315–323CrossRefGoogle Scholar
  22. 22.
    Wang MY, Nowicki D, Anderson G, Jensen J, West B (2008) Liver protective effect of Morinda citrifolia (Noni). Plant Foods for Human Nutrition 63:59–63CrossRefGoogle Scholar
  23. 23.
    Brattin WJ, Glende EA, Recknagel RO (1985) Pathological mechanisms in carbon tetrachloride hepatotoxicity. Free Radic Biol Med 1:27–38CrossRefGoogle Scholar
  24. 24.
    Neely JG, Hartman JM, Forsen JW Jr, Wallace MS (2003) Tutorials in clinical research: VII. Understanding comparative statistics (contrast)—part B: application of T-test, Mann–Whitney U, and chi-square. Laryngoscope 113:1719–1725CrossRefGoogle Scholar
  25. 25.
    El-Shenawy NS, Abdel-Rahman MS (1993) The mechanism of chloroform toxicity in isolated rat hepatocytes. Toxicol Lett 69:77–85CrossRefGoogle Scholar
  26. 26.
    Nkosi CZ, Opoku AR, Terblanche SE (2006) Antioxidative effects of pumpkin seed (Cucurbita pepo) protein isolate in CCl4-induced liver injury in low-protein fed rats. Phytotherapy Res 20:935–940CrossRefGoogle Scholar
  27. 27.
    Jensen CJ, Westendorf J, Wang MY, Wadsworth DP (2006) Noni juice protects the liver. Eur J Gastroenterol Hepatol 18:575–577CrossRefGoogle Scholar
  28. 28.
    Wang MY, Su C (2001) Cancer preventive effect of Morinda citrifolia (Noni). Ann N Y Acad of Sci 952:161–168CrossRefGoogle Scholar
  29. 29.
    Marsh JB (1976) Apoproteins of the lipoproteins in a nonrecirculating perfusate of rat liver. J Lipid Res 17:85–89Google Scholar
  30. 30.
    Pronzato MA, Cottalasso D, Domenicotti C, Tenca C, Traverso N, Nanni G, Marinari UM (1990) Effects of CCl4 poisoning on metabolism of dolichol in rat liver microsomes and Golgi apparatus. Free Radic Res Commun 11:267–277CrossRefGoogle Scholar
  31. 31.
    Chan DC, Barrett PH, Watts GF (2004) Lipoprotein transport in the metabolic syndrome: pathophysiological and interventional studies employing stable isotopy and modelling methods. Clin Sci (London, England) 107:233–249Google Scholar
  32. 32.
    Wang M-Y, Su C, Nowicki D, Jensen J, Anderson G. Protective effect of Morinda citrifolia in carbon tetrachloride-induced liver injury model: A light and electron microscopic study. In: Proceedings of the Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Related Diseases; 2001 October 14–17; 7th Annual Conference; Nashville, Tennessee, USA. (P15)Google Scholar
  33. 33.
    Afanas’ev IB, Dorozhko AI, Brodskii AV, Kostyuk VA, Potapovitch AI (1989) Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem Pharmacol 38:1763–1769CrossRefGoogle Scholar
  34. 34.
    Xiong Q, Fan W, Tezuka Y, Adnyana IK, Stampoulis P, Hattori M, Namba T, Kadota S (2000) Hepatoprotective effect of Apocynum venetum and its active constituents. Planta Medica 66:127–133CrossRefGoogle Scholar
  35. 35.
    Pavanato A, Tuñón MJ, Sánchez-Campos S, Marroni CA, Liesuy S, González-Gallego J, Marroni N (2003) Effects of quercetin on liver damage in rats with carbon tetrachloride-induced cirrhosis. Dig Dis Sci 48:824–829CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Mian-Ying Wang
    • 1
  • Gary Anderson
    • 1
  • Diane Nowicki
    • 1
  • Jarakae Jensen
    • 2
  1. 1.Department of PathologyUniversity of Illinois College of Medicine at RockfordRockfordUSA
  2. 2.Morinda Holdings, Inc., R & D DepartmentAmerican ForkUSA

Personalised recommendations